# A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men

> **NCT01575587** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 51 (actual)

## Conditions studied

- Pharmacology

## Interventions

- **DRUG:** Abiraterone: Treatment A
- **DRUG:** Abiraterone: Treatment B
- **DRUG:** Abiraterone: Treatment C
- **DRUG:** Abiraterone: Treatment D

## Key facts

- **NCT ID:** NCT01575587
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575587, "A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01575587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
